Session Information
2011 Midyear Clinical Meeting
Click here to go to the previous page
ADHD: Treatment Myths and Controversies
Track:
Education Sessions (CE)
Program Code: 216-L01
Date: Monday, December 5, 2011
Time: 4:00 PM to 5:00 PM EST
Location:
Room 289, Level 2
PRESENTER(S):
Elizabeth Farrington
Kimberly Tallian
PROGRAM CHAIR:
Elizabeth Farrington, Pediatric Clinical Specialist
- Compare and contrast recent American Academy of Pediatrics (AAP) and American Heart Association (AHA) recommendations for cardiac monitoring in patients treated with stimulants in Attention Deficit Hyperactivity Disorder (ADHD).
- Describe the contradictory evidence on the usefulness of electrocardiogram (ECG) monitoring to predict acute cardiac death.
- Evaluate the myth that treatment of Attention Deficit Hyperactivity Disorder (ADHD) with stimulants increases substance abuse in later life.
This session is a part of:
This session is a part of: